BUSINESS

Views Of Takeda Pharmaceutical Headquarters As Takeda Loses First Federal Trial Over Actos Diabetes Drug

Takeda is the U.S. arm of Japan's largest pharmaceutical firm. Takeda and Eli Lilly were ordered to pay $9 billion over their diabetes drug, Actos.
Yuzuru Yoshikawa, Bloomberg
Copyright © 2016, Los Angeles Times
70°